Pulmatrix, Inc. — Investor Relations & Filings
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company that develops novel inhaled therapeutic products for respiratory and other diseases. The company's core is its proprietary iSPERSE™ technology, an engineered dry powder platform designed for efficient drug delivery directly to the lungs. This technology aims to improve therapeutic outcomes for patients with serious pulmonary conditions. The company's development pipeline has included candidates for diseases such as Chronic Obstructive Pulmonary Disease (COPD). In late 2024, Pulmatrix announced a proposed merger with Cullgen Inc., a company focused on targeted protein degradation, to form a combined entity with a diversified clinical pipeline.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SC 13G/A | 2022-02-14 | English | |
| Regulatory Filings 2022 | 2022-02-11 | English | |
| AMENDMENT NO. 3 TO SCHEDULE 13G | 2022-02-11 | English | |
| Major Shareholding Notification 2022 | 2022-02-10 | English | |
| Regulatory Filings 2022 | 2022-02-01 | English | |
| Director's Dealing 2022 | 2022-01-31 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
13 filings
| |||||
| 12657253 | SC 13G/A | 2022-02-14 | English | ||
| 12657256 | Regulatory Filings 2022 | 2022-02-11 | English | ||
| 12657257 | AMENDMENT NO. 3 TO SCHEDULE 13G | 2022-02-11 | English | ||
| 12657258 | Major Shareholding Notification 2022 | 2022-02-10 | English | ||
| 12657259 | Regulatory Filings 2022 | 2022-02-01 | English | ||
| 12657263 | Director's Dealing 2022 | 2022-01-31 | English | ||
| 12657266 | Director's Dealing 2022 | 2022-01-31 | English | ||
| 12657268 | Director's Dealing 2022 | 2022-01-31 | English | ||
| 12657270 | Director's Dealing 2022 | 2022-01-29 | English | ||
| 12657273 | Director's Dealing 2022 | 2022-01-29 | English | ||
| 12657274 | Director's Dealing 2022 | 2022-01-29 | English | ||
| 12657275 | Director's Dealing 2022 | 2022-01-29 | English | ||
| 12657277 | SABBY 13G-A PULM 1.05.22 | 2022-01-05 | English | ||
|
2021
2 filings
| |||||
| 12657276 | Regulatory Filings 2021 | 2021-12-30 | English | ||
| 12657278 | Proxy Solicitation & Information Statement 2021 | 2021-12-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Pulmatrix, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35037/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35037 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35037 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35037 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35037}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pulmatrix, Inc. (id: 35037)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.